These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19686517)

  • 41. Global Burden Of Disease Studies: Implications For Mental And Substance Use Disorders.
    Whiteford H; Ferrari A; Degenhardt L
    Health Aff (Millwood); 2016 Jun; 35(6):1114-20. PubMed ID: 27269030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Burden of mental and substance use disorders in Indigenous Australians and Oceania.
    Charlson FJ; Erskine HE
    Australas Psychiatry; 2015 Dec; 23(6 Suppl):13-6. PubMed ID: 26634661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Commentary: improving the mental health and substance use estimates in the Global Burden of Disease study: strengthening the evidence base for public policy.
    Whiteford HA; Degenhardt L; Murray CJ; Vos T; Lopez AD
    Int J Epidemiol; 2014 Apr; 43(2):296-301. PubMed ID: 24639446
    [No Abstract]   [Full Text] [Related]  

  • 44. Developing accuracy when estimating Global Burden of Disease (GBD) in mental and substance use disorders using complex research methodology, refined data analysis and community participation.
    Yearwood EL
    Evid Based Ment Health; 2014 Nov; 17(4):105. PubMed ID: 24667733
    [No Abstract]   [Full Text] [Related]  

  • 45. Reflecting on the global burden of musculoskeletal conditions: lessons learnt from the global burden of disease 2010 study and the next steps forward.
    Hoy DG; Smith E; Cross M; Sanchez-Riera L; Blyth FM; Buchbinder R; Woolf AD; Driscoll T; Brooks P; March LM
    Ann Rheum Dis; 2015 Jan; 74(1):4-7. PubMed ID: 24914071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges and approaches to estimating mortality attributable to the use of selected illicit drugs.
    Warner-Smith M; Lynskey M; Hall W; Monteiro M
    Eur Addict Res; 2001 Aug; 7(3):104-16. PubMed ID: 11509841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The increasing global health priority of substance use in young people.
    Degenhardt L; Stockings E; Patton G; Hall WD; Lynskey M
    Lancet Psychiatry; 2016 Mar; 3(3):251-64. PubMed ID: 26905480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling Illicit Drug Use Dynamics and Its Optimal Control Analysis.
    Mushayabasa S; Tapedzesa G
    Comput Math Methods Med; 2015; 2015():383154. PubMed ID: 26819625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mental disorders as risk factors: assessing the evidence for the Global Burden of Disease Study.
    Baxter AJ; Charlson FJ; Somerville AJ; Whiteford HA
    BMC Med; 2011 Dec; 9():134. PubMed ID: 22176705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The global burden of mental and substance use disorders: changes in estimating burden between GBD1990 and GBD2010.
    Baxter AJ; Ferrari AJ; Erskine HE; Charlson FJ; Degenhardt L; Whiteford HA
    Epidemiol Psychiatr Sci; 2014 Sep; 23(3):239-49. PubMed ID: 24759361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The global recession's effect on drug demand--diluted by inertia.
    Caulkins JP
    Int J Drug Policy; 2011 Sep; 22(5):374-5. PubMed ID: 21429731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The burden of mental disorders.
    Eaton WW; Martins SS; Nestadt G; Bienvenu OJ; Clarke D; Alexandre P
    Epidemiol Rev; 2008; 30():1-14. PubMed ID: 18806255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Applying methods of the global burden of diseases, injuries, and risk factors study to developmental neurotoxicants: a commentary.
    Bellinger DC
    Environ Health; 2018 Jun; 17(1):53. PubMed ID: 29866119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The global burden of drug use and mental disorders.
    Lynskey MT; Strang J
    Lancet; 2013 Nov; 382(9904):1540-2. PubMed ID: 23993279
    [No Abstract]   [Full Text] [Related]  

  • 55. An overview of concepts and approaches used in estimating the burden of congenital disorders globally.
    Moorthie S; Blencowe H; W Darlison M; Lawn JE; Mastroiacovo P; Morris JK; Modell B;
    J Community Genet; 2018 Oct; 9(4):347-362. PubMed ID: 29022220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Challenges to estimating the true global burden of mental disorders.
    Whiteford HA; Ferrari AJ; Vos T
    Lancet Psychiatry; 2016 May; 3(5):402-3. PubMed ID: 27155511
    [No Abstract]   [Full Text] [Related]  

  • 57. The true global disease burden of mental illness: still elusive.
    Vigo D; Jones L; Atun R; Thornicroft G
    Lancet Psychiatry; 2022 Feb; 9(2):98-100. PubMed ID: 35026138
    [No Abstract]   [Full Text] [Related]  

  • 58. Introduction to the Special Issue on Substance Use and Occupational Therapy.
    Rothman EF; Jimenez C
    Subst Abuse; 2023; 17():11782218231160016. PubMed ID: 36923067
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.